A STUDY OF THE EFFECT OF R1507 IN COMBINATION WITH TARCEVA (ERLOTINIB) ON PROGRESSION-FREE SURVIVAL IN PATIENTS WITH STAGE IIIB/IV NON-SMALL CELL LUNG CANCER (NSCLC) HAVING RECEIVED TARCEVA MONOTHERAPY.: